1. OAR@UM
  2. Faculty of Medicine and Surgery
  3. Department of Pathology
  4. Scholarly Works - FacM&SPat
Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/103507
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGamoudi, Donia-
dc.contributor.authorCutajar, Melanie-
dc.contributor.authorGamoudi, Nadia-
dc.contributor.authorCamilleri, David James-
dc.contributor.authorGatt, Alexander-
dc.date.accessioned2022-11-08T14:51:06Z-
dc.date.available2022-11-08T14:51:06Z-
dc.date.issued2017-
dc.identifier.citationGamoudi, D., Cutajar, M., Gamoudi, N., Camilleri, D. J., & Gatt, A. (2017). Achieving a satisfactory clinical and biochemical response in antiphospholipid syndrome and severe thrombocytopenia with rituximab: two case reports. Clinical Case Reports, 5(6), 845.en_GB
dc.identifier.issn20500904-
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/103507-
dc.description.abstractIn AP syndrome (APS) with severe thrombocytopenia, rituximab represents a unique drug which can balance the effect of bleeding and thrombosis. By reducing the production of autoantibodies, rituximab can simultaneously raise the platelets and reduce the chance of thrombosis by suppressing APL antibodies. Rituximab can supersede splenectomy as second-line therapy in similar patients.en_GB
dc.language.isoenen_GB
dc.publisherJohn Wiley & Sons Ltd.en_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectAnticoagulants (Medicine)en_GB
dc.subjectAntiphospholipid syndromeen_GB
dc.subjectRituximaben_GB
dc.subjectThrombocytopeniaen_GB
dc.subjectThrombosisen_GB
dc.titleAchieving a satisfactory clinical and biochemical response in antiphospholipid syndrome and severe thrombocytopenia with rituximab : two case reportsen_GB
dc.typearticleen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedpeer-revieweden_GB
dc.identifier.doi10.1002/ccr3.946-
dc.publication.titleClinical Case Reportsen_GB
Appears in Collections:Scholarly Works - FacM&SPat

Files in This Item:
File Description SizeFormat 
Achieving_a_satisfactory_clinical_and_biochemical_response_in_antiphospholipid_syndrome_and_severe_thrombocytopenia_with_rituximab_two_case_reports(2017).pdf174.74 kBAdobe PDFView/Open
Show simple item record Statistics


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.